ALX ONCOLOGY HOLDINGS INC

ALXO · Nasdaq · SIC 2834: Pharmaceutical Preparations
97
SEC Filings

Business Summary

PART I Item 1. B usiness. BUSINESS Overview We are a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients lives. Our clinical pipeline includes two clinical-stage product candidates, the CD47 blocker evorpacept and an epidermal growth factor receptor (EGFR)-targeted antibody drug candidate (ADC) ALX2004. Our lead product candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of...

Next Earnings

Q2 FY2026 — expected 2026-09-09

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionALXOdiscussed_in_filing Cybersecurity
topic_mentionALXOdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-092025-12-310001193125-26-098454EDGAR100K words
2025-03-062024-12-310000950170-25-034761EDGAR—
2024-03-072023-12-310000950170-24-027955EDGAR—
2023-03-092022-12-310000950170-23-007013EDGAR—
2022-02-282021-12-310001564590-22-007364EDGAR—
2021-03-182020-12-310001564590-21-014169EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-072025-09-300001193125-25-272281EDGAR66K words
2025-08-122025-06-300000950170-25-107303EDGAR—
2025-05-082025-03-310000950170-25-066894EDGAR—
2024-11-072024-09-300000950170-24-123290EDGAR—
2024-08-122024-06-300000950170-24-095391EDGAR—
2024-05-092024-03-310000950170-24-056953EDGAR—
2023-11-132023-09-300000950170-23-062929EDGAR—
2023-08-102023-06-300000950170-23-041319EDGAR—
2023-05-112023-03-310000950170-23-021247EDGAR—
2022-11-082022-09-300000950170-22-023237EDGAR—
2022-08-082022-06-300000950170-22-015553EDGAR—
2022-05-092022-03-310000950170-22-008499EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-270001193125-26-079342EDGAR3K words
2026-01-300001193125-26-030579EDGAR—
2026-01-300001193125-26-030561EDGAR—
2026-01-210001193125-26-018094EDGAR—
2025-11-070001193125-25-271112EDGAR—
2025-09-120001810182-25-000006EDGAR—
2025-08-120000950170-25-107277EDGAR—
2025-06-120000950170-25-085364EDGAR—
2025-05-080000950170-25-066440EDGAR—
2025-04-250000950170-25-058687EDGAR—

97 total filings indexed. 69 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001810182
TickerALXO
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: c64a864db828edc393cebdcb4ee5702ea860f9e61c7d13fc2af7ab8e392d599b
parent: 825ec265cded7cabfb453540ec3c059e379efdc752108abe7d9a42515640f57c
content hash: b1f4a4fa5d6ef0709a7b638ef26abfb34f22f53526d2b983e502eaf334702529
signed: 2026-04-13T04:43:36.808Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf